MANTA Vascular Closure

Device, Hemostasis, Vascular

FDA Premarket Approval P180025

Pre-market Approval Supplement Details

Approval for the 14f manta vascular closure device. The device is indicated for closure of femoral arterial access sites following the use of 10-14f devices or sheaths (maximum od/profile of 18f), and the 18f manta vascular closure device is indicated for closure of femoral arterial access sites following the use of 15-18f devices or sheaths (maximum od/profile of 25f).

DeviceMANTA Vascular Closure
Classification NameDevice, Hemostasis, Vascular
Generic NameDevice, Hemostasis, Vascular
ApplicantEssential Medical, Inc.
Date Received2018-07-09
Decision Date2019-02-01
PMAP180025
SupplementS
Product CodeMGB
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address Essential Medical, Inc. 260 Sierra Drive suite 120 exton, PA 19341

Supplemental Filings

Supplement NumberDateSupplement Type
P180025Original Filing
S009 2021-02-10 Normal 180 Day Track
S008 2020-08-21 30-day Notice
S007 2020-05-04 30-day Notice
S006 2020-01-06 Real-time Process
S005 2019-07-23 30-day Notice
S004
S003
S002 2019-04-18 30-day Notice
S001

NIH GUDID Devices

Device IDPMASupp
00856279007079 P180025 000
00856279007062 P180025 000
20841156109957 P180025 000
20841156109933 P180025 000
20841156109926 P180025 000
20841156109902 P180025 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.